Lilly asked Feds to pause drug pricing negotiations: report

Eli Lilly (NYSE:LLY) has reportedly asked the Biden administration to pause negotiations over drug pricing, citing problems with the process.

Lilly CEO Dave Ricks said in an interview that the company has requested a pause, adding that the government “needed to fix” the